| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
8,138 |
7,418 |
$462K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
11,766 |
2,388 |
$287K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,030 |
2,875 |
$117K |
| J2820 |
Injection, sargramostim (gm-csf), 50 mcg |
197 |
36 |
$87K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,620 |
878 |
$65K |
| 99223 |
Prolong inpt eval add15 m |
831 |
800 |
$53K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,041 |
1,187 |
$53K |
| Q5112 |
Injection, trastuzumab-dttb, biosimilar, (ontruzant), 10 mg |
16 |
12 |
$50K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,265 |
676 |
$40K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,676 |
524 |
$30K |
| J1447 |
Injection, tbo-filgrastim, 1 microgram |
136 |
12 |
$24K |
| 96417 |
|
733 |
494 |
$17K |
| J7050 |
Infusion, normal saline solution, 250 cc |
3,569 |
1,969 |
$16K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
1,827 |
745 |
$15K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
911 |
337 |
$14K |
| J9070 |
Cyclophosphamide, 100 mg |
33 |
12 |
$13K |
| 96367 |
|
532 |
284 |
$12K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
149 |
145 |
$10K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,521 |
628 |
$9K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
772 |
548 |
$9K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,103 |
474 |
$8K |
| 99233 |
Prolong inpt eval add15 m |
206 |
155 |
$7K |
| 96402 |
|
326 |
314 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
74 |
64 |
$2K |
| 96415 |
|
74 |
52 |
$2K |
| J9267 |
Injection, paclitaxel, 1 mg |
56 |
12 |
$1K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
22 |
14 |
$1K |
| J9045 |
Injection, carboplatin, 50 mg |
24 |
13 |
$984.66 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
23 |
14 |
$833.14 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
387 |
356 |
$528.25 |